Logo image of HCTI

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

NASDAQ:HCTI - Nasdaq - US42227W2070 - Common Stock

0.89  -0.01 (-1.11%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HCTI. HCTI was compared to 39 industry peers in the Health Care Technology industry. HCTI has a bad profitability rating. Also its financial health evaluation is rather negative. HCTI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HCTI had negative earnings in the past year.
HCTI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HCTI reported negative net income in multiple years.
HCTI had negative operating cash flow in 4 of the past 5 years.
HCTI Yearly Net Income VS EBIT VS OCF VS FCFHCTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

HCTI has a worse Return On Assets (-208.83%) than 91.89% of its industry peers.
Industry RankSector Rank
ROA -208.83%
ROE N/A
ROIC N/A
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
HCTI Yearly ROA, ROE, ROICHCTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2019 2020 2021 2022 2023 0 1K -1K -2K

1.3 Margins

The Gross Margin of HCTI (25.14%) is worse than 81.08% of its industry peers.
HCTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HCTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
HCTI Yearly Profit, Operating, Gross MarginsHCTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K -100K

More info and screens

2

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCTI has more shares outstanding
HCTI has a worse debt/assets ratio than last year.
HCTI Yearly Shares OutstandingHCTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
HCTI Yearly Total Debt VS Total AssetsHCTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

HCTI has an Altman-Z score of -12.24. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HCTI (-12.24) is worse than 86.49% of its industry peers.
The Debt to FCF ratio of HCTI is 1.14, which is an excellent value as it means it would take HCTI, only 1.14 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HCTI (1.14) is better than 78.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.14
Altman-Z -12.24
ROIC/WACCN/A
WACC16.31%
HCTI Yearly LT Debt VS Equity VS FCFHCTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

HCTI has a Current Ratio of 0.29. This is a bad value and indicates that HCTI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.29, HCTI is doing worse than 91.89% of the companies in the same industry.
A Quick Ratio of 0.29 indicates that HCTI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.29, HCTI is doing worse than 91.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
HCTI Yearly Current Assets VS Current LiabilitesHCTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

HCTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.99%, which is quite impressive.
HCTI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -55.75%.
Measured over the past years, HCTI shows a small growth in Revenue. The Revenue has been growing by 1.94% on average per year.
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCTI Yearly Revenue VS EstimatesHCTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 20M 40M 60M
HCTI Yearly EPS VS EstimatesHCTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCTI Price Earnings VS Forward Price EarningsHCTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HCTI is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.34
EV/EBITDA N/A
HCTI Per share dataHCTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (1/22/2025, 2:11:43 PM)

0.89

-0.01 (-1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15 2023-05-15/amc
Earnings (Next)N/A N/A
Inst Owners2.01%
Inst Owner Change0%
Ins Owners0.54%
Ins Owner Change0%
Market Cap5.05M
Analysts82.86
Price TargetN/A
Short Float %3.73%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF 5.34
P/OCF 5.32
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.17
FCFY18.73%
OCF(TTM)0.17
OCFY18.79%
SpS2.92
BVpS-0.32
TBVpS-0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -208.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.14%
FCFM 5.7%
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
F-Score5
Asset Turnover3.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.14
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -12.24
F-Score5
WACC16.31%
ROIC/WACCN/A
Cap/Depr(3y)106.37%
Cap/Depr(5y)169.41%
Cap/Sales(3y)5.38%
Cap/Sales(5y)6.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.08%
OCF growth 3YN/A
OCF growth 5YN/A